DIALOG iQ
CHALLENGE THE THINKING
DEFINING NEW STANDARDS
BEGINS WITH CHALLENGING CONVENTIONAL THINKING
Progress for B. Braun means continually challenging and encouraging
all employees, customers, physicians, medical professionals and patients
to pursue developments which break new ground and move us forward.
B. Braun’s goal with the Dialog iQ was
to challenge the thinking of today’s current
practices.
Drawing on over fifty years’ experience in How can hemodynamic stability be
dialysis systems technology – and working ensured in dialysis patients?
in constant dialogue with healthcare
professionals – B. Braun is in an excellent hat is the right balance between
W
position to ask the right questions in order elimination and retention in HDF?
to make a real difference in dialysis.
Which treatment situations
require careful online monitoring
of dialysis dose?
How can safety and usability
improve patient satisfaction?
2 3
THE NEW DIALOG iQ
PLACING PATIENTS AT THE CENTER
DEFINING NEW STANDARDS
BEGINS WITH CHALLENGING CONVENTIONAL THINKING
HEMODYNAMIC STABILITY xevonta HDF
The Dialog iQ’s system with two biological Scientific knowledge about the elimination
inputs gives improved information on the of uremic toxins during HDF has been
patient’s hemodynamic condition. growing over recent years. Maybe it is
not only a matter of elimination anymore.
Progress for B. Braun means continually challenging and encouraging
all employees, customers, physicians, medical professionals and patients
to pursue developments which break new ground and move us forward.
B. Braun’s goal with the Dialog iQ was
to challenge the thinking of today’s current
practices.
Drawing on over fifty years’ experience in How can hemodynamic stability be
dialysis systems technology – and working ensured in dialysis patients?
in constant dialogue with healthcare DIALYSIS DOSE SAFETY & USABILITY
professionals – B. Braun is in an excellent hat is the right balance between
W It is important to measure and achieve Ease of use in dialysis equipment means
position to ask the right questions in order elimination and retention in HDF? appropriate dialysis dose for all patients more time to focus on what is most
to make a real difference in dialysis. and in all treatment modes (SNCO, HD, HDF). important – the patients.
Which treatment situations
require careful online monitoring
of dialysis dose?
How can safety and usability Experience how the Dialog iQ can
improve patient satisfaction?
define new standards in renal care.
Download the dedicated
app and discover the new
Dialog iQ from every angle.
2
HEMODYNAMIC STABILITY
BETTER INSIGHTS
FOR BETTER OUTCOMES
System intelligence in medical devices is the a bility to learn from multiple
information sources and take action based on patients’ individual needs.
ABPM – Automatic blood pressure RELATIVE BLOOD VOLUME is a good
measurement addition to blood pressure readings
··
The most direct insight into a patient’s ··Gives insight into vascular refilling
hemodynamic status ··No additional disposables required
··New system increases patient comfort
by reducing the pressures of actual OXYGEN SATURATION gives a new insight
measurement and the time required into the patient’s condition
··Continuous monitoring of arterial (fistula)
or venous (catheter) oxygen saturation
during treatment
·· Clinical observations suggest that
intradialytic hypoxemias are associated
with morbid events such as hypotension
Scan QR code to
and cramps1
see the bioLogic
animation
SIX INDEPENDENT PROFILES are designed
for full patient individualization
··The only dialysis system with temperature,
dialysate and heparin profiles
BIOLOGIC FUSION is system intelligence ·· Patient profiles are easily stored with
··Two biological input parameters - blood NEXADIA or with patient card
pressure and relative blood volume
·· Adaptive system that learns, supporting
GOOD TO KNOW …
patient individualization
Blood volume monitoring alone is not
sufficient to ensure hemodynamic
stability in dialysis patients.2
REFERENCES
1 M eyring-Wösten A et al. Intradialytic Hypoxemia and Clinical Outcomes in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2016 Apr
7;11(4):616-25.
2 Booth J et al. Do changes in relative blood volume monitoring correlate to hemodialysis-associated hypotension? Nephron Clin Pract.
2011;117(3):c179-83.
4 5
xevonta HDF DIALYSIS DOSE
INTELLIGENCE IN HDF DIALYSIS DOSE
ACHIEVING THE BALANCE BETWEEN MORE THAN JUST MONITORING CLEARANCE
ELIMINATION AND RETENTION
The focus to date in convective therapies has been the efficient elimination Despite an increasing trend in the prescription of convective therapies, clearance of small molecules
of uremic toxins. In particular, the subgroup of middle molecules is a point of is still important, particularly in patients starting dialysis or having difficult vascular access.
medical and scientific discussion. However, attention must also be drawn to
substances that should be retained, e.g., proteins such as serum albumin.
IMPORTANCE OF SERUM ALBUMIN ADIMEA –THE REAL INSIGHT INTO TREATMENT QUALITY
··Marker for nutritional and inflammatory status ··
Adimea provides more information than a simple clearance
of maintenance dialysis patients1 monitoring
·· Strong predictor for mortality2 ··Data shown consists of patient, access and dialyzer information
·· Not just Kt/V: eKt/V, spKt/V, URR and UV-absorbance curves are
xevonta allows a efficient elimination of also available, providing doctors and clinical staff with valuable
middle molecules and other uremic toxins, additional insights
but restricts the loss of serum albumin
to 1.1 g ± 0.2 g/session with xevonta
with the largest surface area of
2.3 m² when used under post- Arterial Venous NEW SINGLE-NEEDLE SYSTEM
dilution HDF conditions with expansion chamber expansion chamber is designed for a full treatment
high convective volumes.3 quality with only one pump
··Constant flow through the
Other state-of-the-art dialyzer - only one blood
dialyzers were reported to pump required
eliminate 3.01 g ± 2.37 g/ Arterial
blood pump ·· Reduced extracorporeal
session (FMC FX60, 1.4 m²) blood volume is less stressful
and 4.25 g ± 3.49 g/session for patient’s blood
(FMC FX Cordiax 60, 1.4
Dialyzer ·· Clinical data proves a higher
m²) under post-dilution volume of blood is treated
HDF conditions.4 with Dialog iQ compared to
a system using alternately
Arterial clamp Venous clamp operating pumps1
·· The mean number of access
problems in the first three
GOOD TO KNOW …
months after shunt surgery
Increasing the convective volume during HDF is associated GOOD TO KNOW … is reduced by half when only
Scan
with significant protein loss, mainly albumin.3 Dialysis dose can also be measured by Single Needle Treatments are
QR code
to see Adimea in Single Needle Treatments 3 - performed in this period.2
REFERENCES the SNCO monitoring when it really counts.
1 C linical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation.
animation
Am J Kidney Dis. 2000 Jun;35(6 Suppl 2):S1-140.
2 K alantar-Zadeh K et al. Revisiting mortality predictability of serum albumin in the dialysis population:
time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant. REFERENCES
1 Bieser W et al. Performance of an innovative, one-pump single-needle hemodialysis system versus a standard two-pump single-needle hemodialysis system.
2005 Sep;20(9):1880-8.
3 G ayrard N et al. Influence of high convection volumes in removal performances of on-line haemo- 53rd ERA-EDTA Congress. 2016 May 21-24; Vienna (Austria).
2 Wilson B et al. Impact of single-needle therapy in new chronic hemodialysis starts for individuals with arteriovenous fistulae.
diafiltration (HDF). Nephrol. Dial. Transplant. (2013) 28 (suppl 1): i30-i32.
4 M aduell F et al. Elimination of large uremic toxins by a dialyzer specifically designed for high-volume CANNT J. 2009 Apr-Jun;19(2):23-8.
3 Rawer P et al. Clinical application of real-time Kt/V determination by ultraviolet absorbance (Adimea) in single-needle-cross-over (SNCO)
convective therapies. Blood Purif. 2014;37(2):125-30.
dialysis and hemodiafiltration modes (HDF-online). 47th ERA-EDTA Congress. 2010 June 25-28 Munich (Germany)
6 7
SAFETY & USABILITY
Usability is more than just ease of handling of one
or two components. It is the entire user experience
of the dialysis system. This is why B. Braun invests so
much time during development in dialogue with nurses
and in user evaluations. The end result: We think this
results in confident nurses and satisfied patients.
MORE TIME FOR PATIENT CARE
WHEN SAFETY MEETS USABILITY
RISK PREVENTION SIMPLIFIED PREPARATION
··Risk of blood contamination in the ··One-touch priming
machine is reduced with PODs ·· DiaStream iQ Multiconnector saves
(Pressure Oscillating Diaphragms) time with automated loading and
·· Automated loading of DiaStream iQ ejection of bloodline
reduces risk of repetitive strain injuries ·· Reduced workload in setting up all
therapies, especially single-needle
ENHANCED SAFETY
··
PODs reduce blood-air contact, OPTIMIZED WORKFLOW
reducing clotting ··
Very fast preparation for HD and HDF
··Reduced extracorporeal blood volume, ··Priming during disinfection
in particular in single-needle therapies ··Presetting of dialysis machine, bedside Scan QR code
·· NEXADIA: Fully bidirectional machine documentation and automatic saving
to see
the POD
connectivity reduces probability of of therapy parameters with NEXADIA functionality
errors save up to 21 minutes for the nurse per
session1
GOOD TO KNOW …
Less blood-air contact reduces the risk
of clotting during therapy.2
REFERENCES
1 Osterkorn D et al. Networking for success in dialysis centers: A prospective comperative analysis. Gesundheitsökonomie und
Qualitätsmanagement 2006; 11: 112 - 116
2 Kessler M et al. Anticoagulation in Chronic Hemodialysis: Progress Toward an Optimal Approach. Semin Dial. 2015 Sep-Oct;28(5):474-89.
8 9
SYSTEM OVERVIEW
B. BRAUN 3
SYSTEM PARTNER FOR RENAL CARE
5
2
SERVICES & VALUES PRODUCTS
1. Sharing expertise 1. Dialog iQ
7
2. System provider 2. DiaStream iQ 2
6
1
3. Educational support 3. xevonta
3
4. Applications training 4. Sol-Cart B
4
5. Sustainability 5. Diacan Safety
6. Technical service 6. NEXADIA
7. Clinical support 7. AQUAboss
6
8. Logistics support 8. Concentrates 7
8
5
8
Learn more about the benefits of the new Dialog iQ and our other
innovative products.
For further information,
download the dedicated
app by scanning the QR
code alongside.
10 11
B. Braun Avitum AG | Schwarzenberger Weg 73-79 | 34212 Melsungen | Germany
Tel. +49 5661 71-0 | [email protected] | www.bbraun-dialysis.com
Learn more about the benefits of the new Dialog iQ
and our other innovative products.
For further information, download the dedicated app by
scanning the QR code alongside. 123456789-00
